EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:233980 - AD57
| Formula | C22H20F3N7O |
| Net Charge | 0 |
| Average Mass | 455.444 |
| Monoisotopic Mass | 455.16814 |
| SMILES | CC(C)n1nc(-c2ccc(N/C(O)=N/c3cccc(C(F)(F)F)c3)cc2)c2c(N)ncnc21 |
| InChI | InChI=1S/C22H20F3N7O/c1-12(2)32-20-17(19(26)27-11-28-20)18(31-32)13-6-8-15(9-7-13)29-21(33)30-16-5-3-4-14(10-16)22(23,24)25/h3-12H,1-2H3,(H2,26,27,28)(H2,29,30,33) |
| InChIKey | LEERPLGXOHLQPF-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1). mTOR inhibitor A protein kinase inhibitor of the mammalian target of rapamycin (mTOR), a protein that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis and transcription. mTOR inhibitors are used to prevent transplant rejection and in treatment of cancer. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| AD57 (CHEBI:233980) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434) |
| AD57 (CHEBI:233980) has role mTOR inhibitor (CHEBI:68481) |
| AD57 (CHEBI:233980) is a organic molecular entity (CHEBI:50860) |
| IUPAC Name |
|---|
| 1-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea |
| Citations |
|---|